Professional
Added to YB: 2024-09-24
Pitch date: 2024-06-30
TFX [neutral]
Teleflex Incorporated
-38.44%
current return
Author Info
No bio for this author
Company Info
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
Market Cap
$5.8B
Pitch Price
$214.27
Price Target
N/A
Dividend
1.05%
EV/EBITDA
17.02
P/E
4.2K
EV/Sales
3.84
Sector
Health Care Equipment and Supplies
Category
value
Janus Henderson Contrarian Fund Portfolio Holding: Teleflex Incorporated
TFX: Underperformed despite in-line earnings. UroLift sales underwhelming post-Covid. Conservative 2024 guidance due to recent acquisitions. Attractive valuation with undervalued long-term growth prospects. Monitoring capital allocation for M&A and share repurchases.
Read full article (1 min)